be_ixf;ym_202606 d_01; ct_50
NASDAQ:GT charts & data provided by TradingView

Latest Insights on GT

News-related moves are predictable. And every six weeks, there’s a big move after the Federal Reserve meets. Your 1-Day Trade for This Week’s Fed Meetings October 28, 2019 by Michael Carr Bonds, Government & Politics, Trading Strategies, U.S. Economy, Winning Investor Daily News-related moves are predictable. And every six weeks, there’s a big move after the Federal Reserve meets.
Tesla's Q3 Earnings Tesla’s Q3 Earnings: Slowing Sales and Free Cash Flow Drop October 28, 2019 by Charles Mizrahi American Investor Today, Investing, Technology Tesla’s stock rose by 20% last Wednesday, after the company reported earnings. Headlines touted about the surprising profits for the tech giant. But Charles Mizrahi knows to look beyond the headline hype. He breaks down Tesla’s earnings report for the third quarter of 2019 — and he shows you what the numbers say. (6-minute video)
Walmart breaks through the Halloween wall. Brace yourselves. Christmas is coming! Trade War Update; Amazon Spends Big; Christmas Is Coming October 25, 2019 by Joseph Hargett Great Stuff Friday Four Play: The “It’s Way Too Quiet” Edition If you’ve been following the Great Stuff Trade War Cycle chart, you know that we’ve been stuck at “No progress is made” for about two weeks. There have been no major headlines. No tweets from President Trump. Nothing. It’s been unusually quiet … almost too quiet. […]
Don’t go chasing unicorns; please stick to the indexes and the stocks that you’re used to. WeWork was going to have things its way or nothing at all. WeWork’s Lesson in Unicorn Chasing; Tesla Bears Get Crushed October 24, 2019 by Joseph Hargett Great Stuff The Trouble With Chasing Unicorns I think it’s safe to say that I have a unique sense of humor. That’s putting it politely. It’s definitely not one you find very often in the financial realm. However, the saga of WeWork has brought out the inner cynic in more than a few op-ed writers lately. I […]
biotech ETF and test tubes 1 Biotech ETF to Buy and Ride for the Next 6 Months October 22, 2019 by Chad Shoop American Investor Today, Investing, Investment Opportunities October is a volatile month for the stock market. Last year’s fourth quarter still worries many investors. But Chad Shoop follows a seasonal pattern that historically shows the next six months will be profitable. You don’t want to miss the opportunity to make big money. (4-minute read)

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“Looks like I have finally found the right person to learn and grow from.”

- James

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

Share This